Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK

Journal of Bone and Mineral Research

Volumn 23, Issue 8, 2008, Pages 1227-1237

  Hyun, Woo Lee ^a   Jung, Hee Sun ^a   Kim, Hyun Nam ^b   A, Young Kim ^a   So, Yun Park ^a   Chan, Soo Shin ^c   Choi, Je Yong ^b   Jae, Bum Kim ^a  

^a Seoul National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Berberine; Osteoblast; p38 mitogen activated protein kinase; Phosphorylation; Runx2

Indexed keywords

BERBERINE; CYCLOOXYGENASE 2; HISTONE DEACETYLASE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; OSTEOPONTIN; PROTEIN P300; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ADIPOGENESIS; ANIMALS; ANIMALS, NEWBORN; BERBERINE; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLOOXYGENASE 2; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 47949108989     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080325     Document Type: Article

References (51)

1. Ducy P, Schinke T, Karsenty G 2000 The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:1501-1504.
2. Blair HC, Zaidi M, Schlesinger PH 2002 Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 364:329-341.
3. Yang X, Karsenty G 2002 Transcription factors in bone: Developmental and pathological aspects. Trends Mol Med 8:340-345.
4. Wagner EF, Karsenty G 2001 Genetic control of skeletal development. Curr Opin Genet Dev 11:527-532.
5. Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
6. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
7. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR 1997 Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
8. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
9. Choi JY, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS 2001 Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98:8650-8655.
10. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT 1998 Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 273:32988-32994.
11. Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT 1997 Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol 11:1103-1113.
12. Woodiel FN, Fall PM, Raisz LG 1996 Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res 11:1249-1255.
13. Gasparini G, Longo R, Sarmiento R, Morabito A 2003 Inhibitors of cyclo-oxygenase 2: A new class of anticancer agents? Lancet Oncol 4:605-615.
14. Chun KS, Surh YJ 2004 Signal transduction pathways regulating cyclooxygenase-2 expression: Potential molecular targets for chemoprevention. Biochem Pharmacol 68:1089-1100.
15. Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshio K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC 2002 Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17:1430-1440.
16. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, Qin Y 2006 Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 348:571-578.
17. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB 2006 Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256-2264.
18. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, Nan FJ, Li J 2006 Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta 1760:1682-1689.
19. Li H, Miyahara T, Tezuka Y, Tran QL, Seto H, Kadota S 2003 Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biol Pharm Bull 26:110-111.
20. Seo JB, Moon HM, Kim WS, Lee YS, Jeong HW, Yoo EJ, Ham J, Kang H, Park MG, Steffensen KR, Stulnig TM, Gustafsson JA, Park SD, Kim JB 2004 Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 24:3430-3444.
21. Lee HW, Suh JH, Kim AY, Lee YS, Park SY, Kim JB 2006 Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol Endocrinol 20:2432-2443.
22. Kim KH, Song MJ, Yoo EJ, Choe SS, Park SD, Kim JB 2004 Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J Biol Chem 279:51999-52006.
23. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB 2006 Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55:2562-2570.
24. Garrett IR 2003 Assessing bone formation using mouse calvarial organ cultures. Methods Mol Med 80:183-198.
25. Lian JB, Stein JL, Stein GS, van Wijnen AJ, Montecino M, Javed A, Gutierrez S, Shen J, Zaidi SK, Drissi H 2003 Runx2/ Cbfa1 functions: Diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions. Connect Tissue Res 44(Suppl 1):141-148.
26. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT 2002 Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
27. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD 2004 Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344-1351.
28. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT 2000 MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
29. Mehrotra M, Saegusa M, Voznesensky O, Pilbeam C 2006 Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts. Biochem Biophys Res Commun 341:1225-1230.
30. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949.
31. Jadhav SB, Jain GK 2006 Statins and osteoporosis: New role for old drugs. J Pharm Pharmacol 58:3-18.
32. Li X, Cui Q, Kao C, Wang GJ, Balian G 2003 Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33:652-659.
33. Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J 2000 Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79:557-565.
34. Rosen CJ, Bouxsein ML 2006 Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43.
35. Caplan AI, Bruder SP 2001 Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264.
36. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL 2005 Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146:1226-1235.
37. Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, Park SW, Kim SY, Shin CS 2003 Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278:23270-23277.
38. Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, Bae SC 2006 Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 281:16502-16511.
39. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D 2003 E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/ Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278:27939-27944.
40. Wee HJ, Huang G, Shigesada K, Ito Y 2002 Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep 3:967-974.
41. Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY 2006 Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics 6:1166-1174.
42. Shui C, Spelsberg TC, Riggs BL, Khosla S 2003 Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18:213-221.
43. Javed A, Guo B, Hiebert S, Choi JY, Green J, Zhao SC, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ, Stein GS 2000 Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/ PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci 113:2221-2231.
44. Westendorf JJ 2007 Histone deacetylases in control of skeletogenesis. J Cell Biochem 102:332-340.
45. Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, Van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M 2003 Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23:3339-3351.
46. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB 2005 TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078.
47. Engelman JA, Lisanti MP, Scherer PE 1998 Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273:32111-32120.
48. Zetser A, Gredinger E, Bengal E 1999 p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 274:5193-5200.
49. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J 2003 Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18:2060-2068.
50. Hu Y, Chan E, Wang SX, Li B 2003 Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144:2068-2074.
51. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ 2002 Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.